Geneesmiddelenbeleid
This motion concerns the national policy regarding medicines and pharmaceuticals. It aims to address how medications are managed, priced, or distributed to ensure healthcare sustainability and accessibility for patients. This affects patients, healthcare providers, and pharmaceutical companies by potentially changing how drugs are procured or regulated within the national health system.
National vote coverage: Netherlands-only